These Board Members help to craft the mission, vision and goals of Insulin for Life USA. In addition, they oversee the daily operational activities including fundraising, publicity, obtaining and sending of insulin, and administration. While representing a variety of backgrounds and experiences, each member has one thing in common, a passionate and endless desire to help those with diabetes.
Mark Atkinson, Ph.D.
Dr. Atkinson is currently a Professor of Pathology & Pediatrics and Eminent Scholar for Diabetes Research at The University of Florida, where he also serves as the inaugural Executive Director of the new UF Diabetes Institute. The author of over 375 publications, Dr. Atkinson is beginning his 30th year of investigation into the field of type 1 (insulin dependent) diabetes where he undertakes studies seeking to identify the causes of and a cure for the disease. Dr. Atkinson has been the recipient of multiple scientific and humanitarian based awards for these efforts. He has also been active in a leadership service to the type 1 diabetes community, with administrative or advisory service to The Juvenile Diabetes Research Foundation, The American Diabetes Association, The National Institutes of Health, Diapedia, the Immunology of Diabetes Society, and approximately ten pharmaceutical/biotechnology companies. Finally, he is a member of the Advisory Board for Life for a Child.
Francine Kaufman, M.D.
Dr. Kaufman has devoted more than three decades to the mission of improving the lives of people with diabetes. Her expertise in pediatric type 1 diabetes is exemplified through her involvement with multiple for-profit and not-for-profit organizations, including service on multiple Boards of Directors. A former President of the American Diabetes Association, Dr. Kaufman has served as a delegate to the World Health Organization and was elected to membership in the Institute of Medicine. In addition, she has experience with multiple academic research efforts and patient care initiatives (including international based efforts), currently serves as Chief Medical Officer of Medtronic Diabetes, and carries a defined leadership role with the Medtronic Foundation.
Secretary and Treasurer
Margery Perry has been involved in type 1 diabetes research and advocacy since her daughter Adriana was diagnosed over 26 years ago. She is very active in the diabetes community and has served on multiple non-profit Board of Directors including the International Board of the JDRF as the Chair of Research. Margery also served on the National Institutes of Health Advisory Council for the National Institute of Diabetes and Digestive and Kidney Diseases. Margery remains committed to finding a cure for type 1 diabetes and improving the lives of those that have the disease.
Alicia Jenkins, M.D.
Dr. Jenkins is a diabetes specialist and researcher in Australia. She works clinically as an endocrinologist in Sydney and Melbourne, predominantly in Type 1 diabetes services. She was a key figure in establishing the organization preceding the current Insulin for Life USA in Oklahoma City. Indeed in working with that group, amongst her activities were to develop public awareness for the program, build communication efforts, identify sources for domestic donation of supplies, designating potential sites for distribution of donations, and evaluating medical ethics and need. Today, she continues in these activities. She has been an Insulin for Life Australia and Insulin for Life Global Board Member since 2000. This, alongside of serving as an Advisory Board Member for the International Diabetes Federation Life for a Child program.
Howard Steinberg began his career in brand management at the Pepsi Cola Co. and then started his first company, Source Marketing, in 1989, which grew to be a leader in the promotional marketing industry. Having lived with type 1 diabetes since age 10, he applied his disease understanding along with his marketing and entrepreneurial savvy to form dLife in 2005 to engage this burgeoning population in better 24/7 self-care through a multi-media DTC platform. dLife rapidly became the leading consumer source and trusted BRAND with proven outcomes. Steinberg left dLife in 2012 and he remains active as an investor and advisor to multiple companies from his perch at the Westport Innovation HUB, a co-working center for entrepreneurs and investors, which he founded in 2013.
Dr. Henry Anhalt is a pediatric endocrinologist and the VP, Medical Affairs of Science37. Prior to his appointment at Science37, he was CMO of the T1D Exchange, a nonprofit organization that created a new paradigm fostering collaboration among patients, physicians, researchers and industry to speed discovery of better therapies for type 1 diabetes. He held numerous executive positions in the medical device and biopharmaceutical industries. Dr. Anhalt has held senior leadership positions in many professional organizations and currently serves as chair of the Hormone Health Network of the Endocrine Society. In addition, he serves on the Board of Directors of camp Nejeda, a camp for children with type 1 diabetes.
Howard Halligan, a type 1 diabetic since age 12, has been involved in diabetes research projects and charitable activities for decades. Most notable is his participation in the Diabetes Control and Complications Trial (DCCT) and the Epidemiology of Diabetes Interventions and Complications (EDIC) study, and work as board member and treasurer of the Reader’s Digest Foundation, which supports literacy and education organizations, with an emphasis on employees’ charitable efforts. Professionally, Howard most recently served as chief financial officer and chief operating officer of Trusted Media Brands, Inc., where he collaborated on a myriad of successful initiatives, including the successful launches of the magazine, Every Day with Rachael Ray, and the direct sales company, Taste of Home Entertaining, Inc. He earned both his BS and MBA from New York University, and is a certified public accountant.